Clinical Trials Browser

Phase 2 × Restraint, Physical × Gastrointestinal × Clear all

NCT03714555 2023-10-18

Disulfiram-Copper Gluconate in Met Pancreas Cancer w Rising CA19-9 on Abraxane-Gemzar, FOLFIRINOX or Gemcitabine

Phase 2 Terminated

1 enrolled 7 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms